MiR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I

FEBS Letters

Volumn 588, Issue 23, 2014, Pages 4375-4381

  Song, Bin ^a   Ji, Weiping ^a   Guo, Shiwei ^a   Liu, Anan ^a   Jing, Wei ^a   Shao, Chenghao ^a   Li, Gang ^a   Jin, Gang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cancer growth; miR 545; Pancreatic ductal adenocarcinoma; Patients survival; RIG I

Indexed keywords

MICRORNA; MICRORNA 545; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; MIR545 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS INHIBITION; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN TARGETING; SURVIVAL RATE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84910677316     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.10.004     Document Type: Article

References (34)

1. F. Song, M. He, H. Li, B. Qian, Q. Wei, W. Zhang, K. Chen, and X. Hao A cancer incidence survey in Tianjin: the third largest city in China-between 1981 and 2000 Cancer Causes Control 19 2008 443 450 10.1007/s10552-007-9105-6
2. T.P. Yeo, R.H. Hruban, S.D. Leach, R.E. Wilentz, T.A. Sohn, S.E. Kern, C.A. Iacobuzio-Donahue, A. Maitra, M. Goggins, and M.I. Canto Pancreatic cancer Curr. Probl. Cancer 26 2002 176 275 doi: S0147027202500155([pii])
3. T.S. Riall, J.L. Cameron, K.D. Lillemoe, K.A. Campbell, P.K. Sauter, J. Coleman, R.A. Abrams, D. Laheru, R.H. Hruban, and C.J. Yeo Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - part 3: update on 5-year survival J. Gastrointest. Surg. 9 2005 1191 1204 doi: S1091-255X(05)00668-2 ([pii]) (discussion 1204-1196)
4. A. Maitra, S.E. Kern, and R.H. Hruban Molecular pathogenesis of pancreatic cancer Best Pract. Res. Clin. Gastroenterol. 20 2006 211 226 doi: S1521-6918(05)00155-1 ([pii]10.1016/j.bpg.2005.10.002)
5. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355 10.1038/nature02871 nature02871 [pii]
6. R. Garzon, G.A. Calin, and C.M. Croce MicroRNAs in cancer Annu. Rev. Med. 60 2009 167 179 10.1146/annurev.med.59.053006.104707
7. J. Hou, L. Lin, W. Zhou, Z. Wang, G. Ding, Q. Dong, L. Qin, X. Wu, Y. Zheng, and Y. Yang Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma Cancer Cell 19 2011 232 243 10.1016/j.ccr.2011.01.001 S1535-6108(11)00002-X [pii]
8. D. Li, X. Liu, L. Lin, J. Hou, N. Li, C. Wang, P. Wang, Q. Zhang, P. Zhang, and W. Zhou MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma J. Biol. Chem. 286 2011 36677 36685 10.1074/jbc.M111.270561 M111.270561 [pii]
9. J.T. Mendell, and E.N. Olson MicroRNAs in stress signaling and human disease Cell 148 2012 1172 1187 10.1016/j.cell.2012.02.005 (S0092-8674(12)00162-6 [pii])
10. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat. Rev. Genet. 10 2009 704 714 10.1038/nrg2634 (nrg2634 [pii])
11. P.A. Gregory, A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid, M.A. Vadas, Y. Khew-Goodall, and G.J. Goodall The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat. Cell Biol. 10 2008 593 601 10.1038/ncb1722 (ncb1722 [pii])
12. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, and A. zur Hausen The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat. Cell Biol. 11 2009 1487 1495 10.1038/ncb1998 (ncb1998 [pii])
13. B. Du, Z. Wang, X. Zhang, S. Feng, G. Wang, J. He, and B. Zhang MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells PLoS One 9 2014 e88022 10.1371/journal.pone.0088022 (PONE-D-13-33045 [pii])
14. N. Wu, C. Liu, C. Bai, Y.P. Han, W.C. Cho, and Q. Li Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin Int. J. Mol. Sci. 14 2013 10749 10760 10.3390/ijms140610749 (ijms140610749 [pii])
15. N. Wu, C. Zhang, C. Bai, Y.P. Han, and Q. Li MiR-4782-3p inhibited non-small cell lung cancer growth via USP14 Cell. Physiol. Biochem. 33 2014 457 467 10.1159/000358626 (000358626 [pii])
16. C. Liu, C. Zhang, R.E. Mitchel, J. Cui, J. Lin, Y. Yang, X. Liu, and J. Cai A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance Cell Death Dis. 4 2013 e649 10.1038/cddis.2013.161 (cddis2013161 [pii])
17. J. van Meerloo, G.J. Kaspers, and J. Cloos Cell sensitivity assays: the MTT assay Methods Mol. Biol. 731 2011 237 245 10.1007/978-1-61779-080-5-20
18. Z.B. Han, Z. Yang, Y. Chi, L. Zhang, Y. Wang, Y. Ji, J. Wang, H. Zhao, and Z.C. Han MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151 Cell. Physiol. Biochem. 31 2013 823 832 10.1159/000350100 (000350100 [pii])
19. B. Li, C. Zhang, F. He, W. Liu, Y. Yang, H. Liu, X. Liu, J. Wang, L. Zhang, and B. Deng GSK-3beta inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6 Cell. Physiol. Biochem. 32 2013 1720 1728 10.1159/000356606 (000356606 [pii])
20. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20 S0092867404012607 [pii]10.1016/j.cell.2004.12.035
21. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 19 2009 92 105 10.1101/gr.082701.108 (gr.082701.108 [pii])
22. A. Grimson, K.K. Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol. Cell 27 2007 91 105 doi: S1097-2765(07)00407-8 ([pii] 10.1016/j.molcel.2007.06.017)
23. D.M. Garcia, D. Baek, C. Shin, G.W. Bell, A. Grimson, and D.P. Bartel Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs Nat. Struct. Mol. Biol. 18 2011 1139 1146 10.1038/nsmb.2115 (nsmb.2115 [pii])
24. G. Grentzmann, J.A. Ingram, P.J. Kelly, R.F. Gesteland, and J.F. Atkins A dual-luciferase reporter system for studying recoding signals RNA 4 1998 479 486
25. T. Lv, D. Yuan, X. Miao, Y. Lv, P. Zhan, X. Shen, and Y. Song Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer PLoS One 7 2012 e35065 10.1371/journal.pone.0035065 (PONE-D-11-23836 [pii])
26. N.B. Jamieson, D.C. Morran, J.P. Morton, A. Ali, E.J. Dickson, C.R. Carter, O.J. Sansom, T.R. Evans, C.J. McKay, and K.A. Oien MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma Clin. Cancer Res. 18 2012 534 545 10.1158/1078-0432.CCR-11-0679 (1078-0432.CCR-11-0679 [pii])
27. A.E. Frampton, L. Castellano, T. Colombo, E. Giovannetti, J. Krell, J. Jacob, L. Pellegrino, L. Roca-Alonso, N. Funel, and T.M. Gall MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression Gastroenterology 146 268-277 2014 e218 10.1053/j.gastro.2013.10.010 (S0016-5085(13)01431-5[pii])
28. T. Taniguchi, and A. Takaoka A weak signal for strong responses: interferon-alpha/beta revisited Nat. Rev. Mol. Cell Biol. 2 2001 378 386 10.1038/35073080 (35073080[pii])
29. O. Takeuchi, and S. Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820 10.1016/j.cell.2010.01.022 (S0092-8674(10)00023-1 [pii])
30. D. Luo, S.C. Ding, A. Vela, A. Kohlway, B.D. Lindenbach, and A.M. Pyle Structural insights into RNA recognition by RIG-I Cell 147 2011 409 422 10.1016/j.cell.2011.09.023 (S0092-8674(11)01084-1 [pii])
31. E. Kowalinski, T. Lunardi, A.A. McCarthy, J. Louber, J. Brunel, B. Grigorov, D. Gerlier, and S. Cusack Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA Cell 147 2011 423 435 10.1016/j.cell.2011.09.039 (S0092-8674(11)01150-0 [pii])
32. R. Besch, H. Poeck, T. Hohenauer, D. Senft, G. Hacker, C. Berking, V. Hornung, S. Endres, T. Ruzicka, and S. Rothenfusser Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells J. Clin. Invest. 119 2009 2399 2411 10.1172/JCI37155 37155 [pii]
33. K. Kubler, N. Gehrke, S. Riemann, V. Bohnert, T. Zillinger, E. Hartmann, M. Polcher, C. Rudlowski, W. Kuhn, and G. Hartmann Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells Cancer Res. 70 2010 5293 5304 10.1158/0008-5472.CAN-10-0825 (0008-5472.CAN-10-0825[pii])
34. J. Hou, Y. Zhou, Y. Zheng, J. Fan, W. Zhou, I.O. Ng, H. Sun, L. Qin, S. Qiu, and J.M. Lee Hepatic RIG-I predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma Cancer Cell 25 2014 49 63 10.1016/j.ccr.2013.11.011 (S1535-6108(13)00496-0 [pii])